ResearcherFlorida Agricultural and Mechanical UniversityActive in the last 2 years
Raviteja Bulusu
Matched on ORCID iD 0000-0003-4613-4621; OpenAlex author ID A5032314735. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2022: 2 papers · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers
Papers 8
- Anti-EGFR liposomal drug delivery system loaded with AGY2 potentiates the anti-cancer effect of AGY2 against EGFR expressed pancreatic cancer. Co-author DOI 10.1016/j.ijpx.2026.100544↗
- Targeted Immunoliposomal Delivery of a 5-Fluorouracil Analog in EGFR-Expressing Pancreatic Cancer Models. First author DOI 10.1177/15330338261468414↗
- Enhanced anticancer activity of novel pyrimidine nucleoside analog in pancreatic cancer. Co-author DOI 10.62347/arcz1924↗
- Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-vitro evaluation against pancreatic canc… First author DOI 10.1016/j.ejps.2024.106754↗
- Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer. Co-author DOI 10.1186/s12885-023-10928-w↗
- Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer. Co-author DOI 10.3390/ijms24054288↗
- Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer. Co-author DOI 10.1186/s12885-022-10449-y↗
- Application of modified gemcitabine-loaded solid lipid nanoparticle in the treatment of pancreatic cancer patient-derived xenograft model Co-author DOI 10.21203/rs.3.rs-1777458/v1↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Edward Agyare · 7 shared papers, 2022–2026 · strength 1.51
- Paper Anti-EGFR liposomal drug delivery system loaded with AGY2 potentiates the anti-cancer effect of AGY2 against EGFR expre… DOI 10.1016/j.ijpx.2026.100544↗
- Paper Targeted Immunoliposomal Delivery of a 5-Fluorouracil Analog in EGFR-Expressing Pancreatic Cancer Models. DOI 10.1177/15330338261468414↗
- Paper Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-… DOI 10.1016/j.ejps.2024.106754↗
- Esther Frimpong · 7 shared papers, 2022–2026 · strength 1.51
- Paper Anti-EGFR liposomal drug delivery system loaded with AGY2 potentiates the anti-cancer effect of AGY2 against EGFR expre… DOI 10.1016/j.ijpx.2026.100544↗
- Paper Targeted Immunoliposomal Delivery of a 5-Fluorouracil Analog in EGFR-Expressing Pancreatic Cancer Models. DOI 10.1177/15330338261468414↗
- Paper Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-… DOI 10.1016/j.ejps.2024.106754↗
- Joy C. Okoro · 4 shared papers, 2023–2026 · strength 1.03
- Paper Anti-EGFR liposomal drug delivery system loaded with AGY2 potentiates the anti-cancer effect of AGY2 against EGFR expre… DOI 10.1016/j.ijpx.2026.100544↗
- Paper Targeted Immunoliposomal Delivery of a 5-Fluorouracil Analog in EGFR-Expressing Pancreatic Cancer Models. DOI 10.1177/15330338261468414↗
- Paper Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-… DOI 10.1016/j.ejps.2024.106754↗
- Andriana Inkoom · 5 shared papers, 2022–2024 · strength 0.88
- Paper Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-… DOI 10.1016/j.ejps.2024.106754↗
- Paper Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer. DOI 10.1186/s12885-023-10928-w↗
- Paper Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer. DOI 10.3390/ijms24054288↗
- Nkafu Bechem Ndemazie · 5 shared papers, 2022–2024 · strength 0.88
- Paper Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-… DOI 10.1016/j.ejps.2024.106754↗
- Paper Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer. DOI 10.1186/s12885-023-10928-w↗
- Paper Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer. DOI 10.3390/ijms24054288↗
- Bo Han · 5 shared papers, 2022–2024 · strength 0.88
- Paper Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-… DOI 10.1016/j.ejps.2024.106754↗
- Paper Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer. DOI 10.1186/s12885-023-10928-w↗
- Paper Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer. DOI 10.3390/ijms24054288↗
- Saunjoo Yoon · 2 shared papers, 2026 · strength 0.63
- Paper Anti-EGFR liposomal drug delivery system loaded with AGY2 potentiates the anti-cancer effect of AGY2 against EGFR expre… DOI 10.1016/j.ijpx.2026.100544↗
- Paper Targeted Immunoliposomal Delivery of a 5-Fluorouracil Analog in EGFR-Expressing Pancreatic Cancer Models. DOI 10.1177/15330338261468414↗
- Jose Gilberto Trevino · 3 shared papers, 2022–2023 · strength 0.49
- Paper Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer. DOI 10.1186/s12885-023-10928-w↗
- Paper Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for panc… DOI 10.1186/s12885-022-10449-y↗
- Paper Application of modified gemcitabine-loaded solid lipid nanoparticle in the treatment of pancreatic cancer patient-deriv… DOI 10.21203/rs.3.rs-1777458/v1↗
- Sherise Chantell Rogers · 2 shared papers, 2023–2024 · strength 0.40
- Paper Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-… DOI 10.1016/j.ejps.2024.106754↗
- Paper Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer. DOI 10.3390/ijms24054288↗
- Sunil Krishnan Krishnan · 1 shared paper, 2026 · strength 0.32
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.